Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HIFU With or Without Sintilimab Followed by Chemo in TNBC
NCT07394387Phase 2Recruiting
- Sponsor
- Jiangsu Provincial People's Hospital
- Start
- Jan 2025
- Primary completion
- Jun 2026
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of sintilimab in triple-negative breast cancer (TNBC), sponsored by Jiangsu Provincial People's Hospital. Started Jan 2025; status: recruiting.
02
Drugs
sintilimab
03
Conditions
triple-negative breast cancer (TNBC)
Beyond the preview
Go deeper on NCT07394387.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07394387.